✦ LIBER ✦

Pharmacokinetics and Modeling of Quercetin and Metabolites

✍ Scribed by Xiao Chen; Ophelia Q. P. Yin; Zhong Zuo; Moses S. S. Chow

Book ID: 106492568
Publisher: Springer US
Year: 2005
Tongue: English
Weight: 513 KB
Volume: 22
Category: Article
ISSN: 0724-8741
DOI: 10.1007/s11095-005-4584-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of quercetin from querc

Pharmacokinetics of quercetin from quercetin aglycone and rutin in healthy volunteers

✍ I. Erlund; T. Kosonen; G. Alfthan; J. Mäenpää; K. Perttunen; J. Kenraali; J. Par 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 161 KB

Quercetin pharmacokinetics in humans

✍ Young J. Moon; Liang Wang; Robert DiCenzo; Marilyn E. Morris 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Atracurium, pharmacokinetics and metabol

Atracurium, pharmacokinetics and metabolites

✍ François Donati 📂 Article 📅 1989 🏛 Springer-Verlag 🌐 French ⚖ 325 KB

Pharmacokinetics of chlorpromazine and k

Pharmacokinetics of chlorpromazine and key metabolites

✍ P. K. -F. Yeung; J. W. Hubbard; E. D. Korchinski; K. K. Midha 📂 Article 📅 1993 🏛 Springer 🌐 English ⚖ 714 KB

Population Pharmacokinetics of Nicotine

Population Pharmacokinetics of Nicotine and Its Metabolites I. Model Development

✍ Micha Levi; Delia A. Dempsey; Neal L. Benowitz; Lewis B. Sheiner 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 355 KB

Integrated pharmacokinetic and metabolic

Integrated pharmacokinetic and metabolic modeling of selegiline and metabolites after transdermal administration

✍ Shashank Rohatagi; Jeffrey S. Barrett; Kimberly E. Dewitt; Richard J. Morales 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 2 views

Selegiline (SEL) is a selective, irreversible inhibitor of MAO-B, used in the treatment of Parkinson's disease, either alone or as an adjunct to L-DOPA. Selegiline hydrochloride (HCl) undergoes significant first-pass metabolism following oral administration. Transdermal delivery avoids the first-pas